Home > Magazine > Society

March 2012 Member News & Networking

Feb 21, 2012

Soumit K. Basu, MD, PhD, joined the Osborn Hematopoietic Malignancy and Transplantation Program at the West Virginia University (WVU) Mary Babb Randolph Cancer Center. Before joining WVU, Dr. Basu was acting instructor in the Division of Hematology at the University of Washington Fred Hutchinson Cancer Research Center.  
     
More than 300 community members joined ASCO Connection Editor-in-Chief and Stanford Women’s Cancer Center (SWCC) Director Jonathan S. Berek, MD, MMS; Stanford University President John L. Hennessy; Stanford Hospital & Clinics CEO Amir Dan Rubin; Stanford Cancer Institute Director Beverly S. Mitchell, MD, and others during the third annual Under One Umbrella benefit for SWCC. Sheryl Crow—singer/songwriter/record producer/actress—lent her star power to the event, held November 18, 2011, which helped raise more than $1 million.
     
Researchers at the University of Michigan (U-M) Health System found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies. Douglas B. Chepeha, MD, MSPH, served as senior author of the study, which was published in the January 13, 2012, edition ofHead & Neck.  
     
Ezra Cohen, MD, Associate Professor of Medicine at the University of Chicago Comprehensive Cancer Center, recently became Associate Director for Education. In this new position, Dr. Cohen will expand, integrate, and coordinate cancer-related educational efforts for trainees as well as health care professionals at The University of Chicago.  
     
Lucy Godley, MD, PhD, of the University of Chicago Comprehensive Cancer Center, was elected to the American Society of Clinical Investigation. Dr. Godley was chosen for her contributions to cancer biology research, specifically her work in uncovering the molecular mechanisms that drive tumorigenesis.  
     
Andrzej Jakubowiak, MD, PhD, joined University of Chicago as a Professor of Medicine in the Section of Hematology/Oncology and as Director of the Myeloma Program. Dr. Jakubowiak is a national leader in the development of new drugs for the treatment of multiple myeloma.  
     
V. Craig Jordan, OBE, PhD, DSc, FMedSci, of Georgetown University Medical Center, was selected as recipient of the 2012 ASPET Goodman and Gillman Award in Drug Receptor Pharmacology by the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dr. Jordan was selected because of his contributions in developing the breast cancer drug tamoxifen.  
     
Lisa A. Mills, MD; Jennifer G. Reeder, MD; and Michael B. Wax, MD, of Summit Medical Group, were honored by the American Cancer Society, Metro NJ Region, for their work in promoting the importance of cancer screenings and follow-up appointments, educating patients about what to expect from cancer treatment, and providing exemplary patient care.  
  (L-R) Dr. Reeder, Dr. Wax, and Dr. Mills | Courtesy of SUMMIT MEDICAL GROUP
     
Olatoyosi Odenike, MD, of the University of Chicago Comprehensive Cancer Center, was promoted to Associate Professor of Medicine. As a clinician, Dr. Odenike provides expert care to adult patients with leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes.  
     
William Pao, MD, PhD, and Mia Levy, MD, PhD, of Vanderbilt-Ingram Cancer Center—who created the online medical decision support tool “My Cancer Genome”—were named winners of a $20,000 health care technology award sponsored by NCI. The contest was presented as part of the Office of the National Coordinator for Health Information Technology’s Investing in Innovation (i2) program.  
     
Researchers from the U-M Comprehensive Cancer Center found that a natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease. Pavan Reddy, MD, served as senior author of the study, which was published in the January 10, 2012, edition of the Proceedings of the National Academy of Science.  
     
The University of Michigan (U-M) Comprehensive Cancer Center and Michigan Center for Translational Pathology completed a pilot study aimed at solving the practical challenges involved in quickly and systematically sequencing genetic material from patients with advanced or treatment-resistant cancer in order to match them with existing clinical trials based on the biomarkers identified. U-M physicians Moshe Talpaz, MD, Stephen Gruber, MD, PhD, and Kenneth J. Pienta, MD, played key roles in the clinical implementation of this exploratory protocol.

 


In Memoriam

  • Margarida Dederick, MD
  • Donna Mae Fukumoto, MD
  • Donald G. Gallup, MD
  • Saswati Gupta, MD
  • Heine H. Hansen, MD, PhD, FRCP*
  • Mahesh Durgadas Kanojia, MD
  • Maimu Ohanian, MD

* Expanded tribute article


Send yoursubmissionsfor Member News& Networking toascoconnection@asco.org.


Advertisement
Back to Top